Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Matriptase, also known as ST14, is a type II transmembrane serine protease that plays essential roles in physiological processes and disease. It is widely expressed in most human epithelial tissues and functions as an epithelial membrane activator for other proteases and growth factors. Key roles include skin barrier formation, epidermal differentiation, and regulation of intestinal epithelial barrier integrity. Dysregulation of matriptase has been implicated in cancer, genetic disorders, and inflammatory diseases, making it a potential target for anti-cancer therapy.
Serine protease inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Matriptase (None).